Organization · Venture Capital
LongevityTech.fund
LongevityTech.fund is a venture capital firm focused on investing in early-stage startups and university spinoffs in the longevity sector. Based in the United States, it aims to extend healthy human lifespan through innovations in biotechnology and related fields.
Overview
What LongevityTech.fund does
What LongevityTech.fund is
LongevityTech.fund is a venture capital firm focused on investing in early-stage startups and university spinoffs in the longevity sector. Based in the United States, it aims to extend healthy human lifespan through innovations in biotechnology and related fields.
How it participates in the startup ecosystem
The current public profile supports funder capabilities. Each capability below is shown separately so organization identity and role-specific information do not get conflated.
Operational profile
Organization status and context
Organization status describes the entity itself. Funding and program availability appear within the relevant capability profile.
- Operational status
- Active
- Organization type
- Venture Capital
- Founded
- Founded in 2019
- Approximate age
- About 7 years
- Structured capabilities
- Funder
- Last reviewed
- May 5, 2026
Official channels
Find LongevityTech.fund elsewhere
Open the official website or a supported primary organization account.
Capability profile
LongevityTech.fund as a funder
Investment thesis
LongevityTech.fund focuses on extending healthy human lifespan and improving healthspan through investments in innovative longevity solutions.
Focus narrative
The fund invests in early-stage ventures, particularly in the longevity space, including biotechnology, diagnostics, and health technologies. Their investment strategy emphasizes companies that show potential for significant impact in extending human life and improving health outcomes. By targeting pre-seed, seed, and Series A startups, LongevityTech.fund aims to capture the wave of innovation in longevity and healthspan enhancement.
Value beyond capital
LongevityTech.fund adds value to its portfolio companies through scientific expertise, mentoring, and support in intellectual property and commercialization. The fund provides access to a network of longevity scientists and investors, helping startups navigate the complexities of the longevity market and accelerate their growth.
Focus and fit
- Stages
- Pre-seed · Seed · Series A
- Regions
- Global · North America · Europe
Availability
- Currently deploying
- Yes
Portfolio and track record
- Recorded portfolio count
- 40
Portfolio context
LongevityTech.fund's portfolio includes notable companies such as Remedium Bio, a gene-therapy company focused on age-related diseases; SiPhox Health, which specializes in home diagnostics; and MitoRx Therapeutics, known for its mitochondrial-protective therapies. Other portfolio companies include SENISCA, Repair Biotechnologies, and BrainKey.ai, all contributing to advancements in longevity and health technologies.
Common questions
What to know about LongevityTech.fund
Upseed classifies LongevityTech.fund under the Venture Capital organization type. Its current public profile includes funder capabilities.
Source and update disclosure
Know what this page is based on
Source basis
Public organization and program material, official websites, and structured Upseed records.
Last reviewed
May 5, 2026
Known limits
Capability profiles appear only when a structured public profile also contains decision-useful role evidence. Terms and availability can change.
Upseed is an independent guide. It is not affiliated with or endorsed by the organization described on this page.